APAC Vagus Nerve Stimulation Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143050
- Pages: 225
-
Format:
Short Description
Asia-Pacific Vagus Nerve Stimulation Market, By Product Type (Implantable VNS Devices and External VNS Devices), Biomaterial (Ceramics, Metallic, and Polymerics), Application (Pain Management, Epileptic Seizures, Obesity Management, Depression and Anxiety, and Others), Patient Type (Adults, Pediatric, and Geriatric), End User (Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Philippines, Indonesia, and Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Market Definition
The vagus nerve is a long cranial nerve that runs from a persons brain stem into the neck, chest, and abdomen. It is a part of the parasympathetic nervous system, which is commonly referred to as the rest-and-digest system because it regulates bodily functions while a person is at rest. It delivers messages to a persons brain from their digestive system and organs such as their lungs, heart, and liver. It controls several organ functions, including digestion, heart rate, and respiratory rate. It is responsible for vasomotor activity and reflexes. It also regulates vocalization, mood, and immunity. It influences sensory functions in a persons ears, sinuses, and esophagus as well.
Vagus Nerve Stimulation (VNS) involves a pulse generator inserted under a persons skin on their chest. The implantable device, which is similar to a pacemaker, delivers regular electrical pulses to the brain via the vagus nerve. It is possible to provide additional stimulation by placing the provided magnet over the pulse generator. Relaxation techniques such as breathing exercises, yoga, and medication can influence vagus nerve activity, increasing its ability to relieve anxiety and mood-related symptoms. VNS can improve an individuals physical health and can offer benefits for several conditions such as epilepsy and depression. The treatment has a healing effect on a persons body due to its ability to promote relaxation and reduce inflammation.
Market Segmentation
Asia-Pacific vagus nerve stimulation market is categorized into six notable segments based on product type, biomaterial, application, patient type, end user, and distribution channel.
Based on product type, the market is segmented into implantable VNS devices and external VNS devices
Based on biomaterial, the market is segmented into ceramics, metallic, and polymerics
Based on application, the market is segmented into pain management, epileptic seizures, obesity management, depression and anxiety, and others
Based on patient type, the market is segmented into adults, pediatrics, and geriatrics
Based on end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others
Based on distribution channel, the market is segmented into direct tender, retail sales, and others
Market Players
Some of the key market players in the Asia-Pacific vagus nerve stimulation market are listed below:
electroCore, Inc.
LivaNova PLC
Medtronic
SetPoint Medical
tVNS Technologies GmbH
MicroTransponder Inc.
Neuropix Company Ltd.
Others
TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF ASIA PACIFIC VAGUS NERVE STIMULATION MARKET 20
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22
2 MARKET SEGMENTATION 24
2.1 MARKETS COVERED 24
2.2 GEOGRAPHICAL SCOPE 25
2.3 YEARS CONSIDERED FOR THE STUDY 26
2.4 CURRENCY AND PRICING 26
2.5 DBMR TRIPOD DATA VALIDATION MODEL 27
2.6 MULTIVARIATE MODELLING 30
2.7 LIFELINE CURVE , BY PRODUCT TYPE 30
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.9 DBMR MARKET POSITION GRID 32
2.10 MARKET APPLICATION COVERAGE GRID 33
2.11 VENDOR SHARE ANALYSIS 34
2.12 SECONDARY SOURCES 35
2.13 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 39
4.1 PORTERS FIVE FORCES 40
4.2 PESTEL ANALYSIS 41
4.3 KEY STRATEGIC INITIATIVES 42
5 REGULATIONS OF ASIA PACIFIC VAGUS NERVE STIMULATION MARKET 43
6 MARKET OVERVIEW 47
6.1 DRIVERS 49
6.1.1 INCREASING PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS 49
6.1.2 INNOVATIVE NON-INVASIVE VAGUS NERVE STIMULATION DEVICES INTRODUCED TO MEET DEMAND 50
6.1.3 RISE IN PRODUCT APPROVALS 50
6.1.4 PRODUCT DEVELOPMENT IN RECENT YEARS 51
6.2 RESTRAINTS 51
6.2.1 HIGH MAINTENANCE AND DEVICE COSTS TO RESTRAIN ADOPTION OF VAGUS NERVE STIMULATORS 51
6.2.2 RISE IN PRODUCT RECALL 52
6.2.3 UNFAVORABLE REIMBURSEMENT POLICIES 52
6.3 OPPORTUNITIES 53
6.3.1 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 53
6.3.2 RISING GOVERNMENT INITIATIVES FOR NEUROLOGICAL DISEASE 53
6.4 CHALLENGES 54
6.4.1 RISKS ASSOCIATED WITH THE IMPLANTATION OF THESE DEVICES 54
6.4.2 LACK OF SKILLED HEALTHCARE PROFESSIONALS 54
6.4.3 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES 55
7 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE 56
7.1 OVERVIEW 57
7.2 IMPLANTABLE VNS DEVICE 60
7.3 EXTERNAL VNS DEVICE 60
8 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL 61
8.1 OVERVIEW 62
8.2 METALLIC 65
8.3 POLYMERIC 65
8.4 CERAMICS 66
9 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION 67
9.1 OVERVIEW 68
9.2 EPILEPTIC SEIZURES 71
9.2.1 IMPLANTABLE VNS DEVICE 71
9.2.2 EXTERNAL VNS DEVICE 71
9.3 DEPRESSION AND ANXIETY 71
9.3.1 IMPLANTABLE VNS DEVICE 72
9.3.2 EXTERNAL VNS DEVICE 72
9.4 PAIN MANAGEMENT 73
9.4.1 IMPLANTABLE VNS DEVICE 73
9.4.2 EXTERNAL VNS DEVICE 73
9.5 OBESITY MANAGEMENT 74
9.5.1 IMPLANTABLE VNS DEVICE 74
9.5.2 EXTERNAL VNS DEVICE 74
9.6 OTHERS 75
10 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE 76
10.1 OVERVIEW 77
10.2 ADULTS 80
10.2.1 IMPLANTABLE VNS DEVICES 80
10.2.2 EXTERNAL VNS DEVICES 80
10.3 GERIATRIC 81
10.3.1 IMPLANTABLE VNS DEVICES 81
10.3.2 EXTERNAL VNS DEVICES 81
10.4 PEDIATRIC 82
10.4.1 IMPLANTABLE VNS DEVICES 82
10.4.2 EXTERNAL VNS DEVICES 82
11 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER 83
11.1 OVERVIEW 84
11.2 SPECIALTY CENTERS 87
11.3 HOSPITALS 87
11.4 AMBULATORY SURGICAL CENTERS (ASCS) 88
11.5 OTHERS 88
12 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL 89
12.1 OVERVIEW 90
12.2 DIRECT TENDER 93
12.3 RETAIL SALES 93
12.4 OTHERS 94
13 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY REGION 95
13.1 ASIA-PACIFIC 96
13.1.1 CHINA 105
13.1.2 JAPAN 109
13.1.3 SOUTH KOREA 113
13.1.4 INDIA 117
13.1.5 AUSTRALIA 121
13.1.6 SINGAPORE 125
13.1.7 THAILAND 129
13.1.8 MALAYSIA 133
13.1.9 INDONESIA 137
13.1.10 PHILIPPINES 141
13.1.11 REST OF ASIA-PACIFIC 145
14 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: COMPANY LANDSCAPE 146
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 146
15 SWOT ANALYSIS 147
16 COMPANY PROFILE 148
16.1 ELECTROCORE, INC. 148
16.1.1 COMPANY SNAPSHOT 148
16.1.2 REVENUE ANALYSIS 148
16.1.3 COMPANY SHARE ANALYSIS 149
16.1.4 PRODUCT PORTFOLIO 149
16.1.5 RECENT DEVELOPMENTS 149
16.2 LIVANOVA PLC 151
16.2.1 COMPANY SNAPSHOT 151
16.2.2 REVENUE ANALYSIS 151
16.2.3 COMPANY SHARE ANALYSIS 152
16.2.4 PRODUCT PORTFOLIO 152
16.2.5 RECENT DEVELOPMENTS 152
16.3 MEDTRONIC 154
16.3.1 COMPANY SNAPSHOT 154
16.3.2 REVENUE ANALYSIS 154
16.3.3 COMPANY SHARE ANALYSIS 155
16.3.4 PRODUCT PORTFOLIO 155
16.3.5 RECENT DEVELOPMENTS 155
16.4 SETPOINT MEDICAL 156
16.4.1 COMPANY SNAPSHOT 156
16.4.2 COMPANY SHARE ANALYSIS 156
16.4.3 PRODUCT PORTFOLIO 157
16.4.4 RECENT DEVELOPMENTS 157
16.5 TVNS TECHNOLOGIES GMBH 158
16.5.1 COMPANY SNAPSHOT 158
16.5.2 COMPANY SHARE ANALYSIS 158
16.5.3 PRODUCT PORTFOLIO 159
16.5.4 RECENT DEVELOPMENT 159
16.6 NEUROPIX COMPANY LTD. 160
16.6.1 COMPANY SNAPSHOT 160
16.6.2 PRODUCT PORTFOLIO 160
16.6.3 RECENT DEVELOPMENT 160
16.7 BRAIN CONTROL CO. LTD 161
16.7.1 COMPANY SNAPSHOT 161
16.7.2 PRODUCT PORTFOLIO 161
16.7.3 RECENT DEVELOPMENTS 161
16.8 CIRTEC 162
16.8.1 COMPANY SNAPSHOT 162
16.8.2 PRODUCT PORTFOLIO 162
16.8.3 RECENT DEVELOPMENTS 162
16.9 MICROTRANSPONDER INC. 163
16.9.1 COMPANY SNAPSHOT 163
16.9.2 PRODUCT PORTFOLIO 163
16.9.3 RECENT DEVELOPMENT 163
16.10 PARASYM LTD 164
16.10.1 COMPANY SNAPSHOT 164
16.10.2 PRODUCT PORTFOLIO 164
16.10.3 RECENT DEVELOPMENT 164
16.11 RESHAPE LIFESCIENCES INC. (2021) 165
16.11.1 COMPANY SNAPSHOT 165
16.11.2 REVENUE ANALYSIS 165
16.11.3 PRODUCT PORTFOLIO 166
16.11.4 RECENT DEVELOPMENT 166
16.12 SOTERIX MEDICAL INC. 167
16.12.1 COMPANY SNAPSHOT 167
16.12.2 PRODUCT PORTFOLIO 167
16.12.3 RECENT DEVELOPMENTS 167
17 QUESTIONNAIRE 168
18 RELATED REPORTS 171
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
